Scientists test Four-Drug cocktail in fight against tough cancers
NCT ID NCT01087554
Summary
This early-stage study aims to find the safest and most effective doses of combining the drug vorinostat with one of three other cancer drugs (sirolimus, everolimus, or temsirolimus) in patients with advanced cancer that hasn't responded to standard treatments. Researchers will enroll up to 249 patients to test different dose levels and monitor for side effects. The goal is to control cancer growth and see if these drug combinations are tolerable and show promise for future treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.